These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 629327
1. Inhibition of human neutrophil oxidative metabolism and degranulation in vitro by nitroblue tetrazolium and vitamin E. Repine JE, Rao G, Beall GD, White JG. Am J Pathol; 1978 Mar; 90(3):659-74. PubMed ID: 629327 [Abstract] [Full Text] [Related]
2. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. White JG, Rao GH, Gerrard JM. Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276 [Abstract] [Full Text] [Related]
3. Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes. Fattorossi A, Nisini R, Le Moli S, De Petrillo G, D'Amelio R. Cytometry; 1990 Aug; 11(8):907-12. PubMed ID: 2272251 [Abstract] [Full Text] [Related]
4. Vitamin E and platelets: cooperative interactions with nitroblue tetrazolium on inhibition of adhesion, aggregation and secretion. White JG, Rao GH, Gerrard JM. Am J Pediatr Hematol Oncol; 1979 Aug; 1(2):155-68. PubMed ID: 396798 [Abstract] [Full Text] [Related]
5. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers. Johansen KS. Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):349-54. PubMed ID: 6673503 [Abstract] [Full Text] [Related]
6. The effect of VP 16-213 on NBT reduction in the normal polymorphonuclear neutrophil. Bender JW. Cancer Biochem Biophys; 1980 Dec; 4(4):233-6. PubMed ID: 7448746 [Abstract] [Full Text] [Related]
7. The influence of phorbol myristate acetate on the metabolism of neutrophils from carriers of sex-linked chronic granulomatous disease. Repine JE, White JG, Clawson CC, Holmes BH. J Lab Clin Med; 1975 Jan; 85(1):82-6. PubMed ID: 1141733 [Abstract] [Full Text] [Related]
8. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease. Roberts RL, Ohno Y, Gallin JI. Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626 [Abstract] [Full Text] [Related]
14. Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease. Ahlin A, Gyllenhammar H, Ringertz B, Palmblad J. J Lab Clin Med; 1995 Mar; 125(3):392-401. PubMed ID: 7897306 [Abstract] [Full Text] [Related]
15. Opsonization of pneumococci. II. Metabolic effects of a "third" human serum activity that mediates intracellular killing. Guckian JC, Cavallo T, Fine DP. J Immunol; 1981 Oct; 127(4):1666-70. PubMed ID: 7276578 [Abstract] [Full Text] [Related]
17. [Effect of interferon on the increased reduction of nitroblue tetrazolium (NBT)]. Imanishi J, Pak CB, Kishida T. C R Seances Soc Biol Fil; 1979 Oct; 173(5):1004-7. PubMed ID: 161180 [Abstract] [Full Text] [Related]
18. Quantitative measurement of the bactericidal capability of neutrophils from patients and carriers of chronic granulomatous disease. Repine JE, Clawson CC. J Lab Clin Med; 1977 Sep; 90(3):522-8. PubMed ID: 408453 [Abstract] [Full Text] [Related]
19. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases. Briggs RT, Karnovsky ML, Karnovsky MJ. J Clin Invest; 1977 Jun; 59(6):1088-98. PubMed ID: 193872 [Abstract] [Full Text] [Related]